Another initiative towards Atmanirbhar Bharat – Made in India vaccine brands
Not just winning global vaccine diplomacy, but Indian brands stand out in creating the most promising brand perception among Indians
Bengaluru, March 2021: Velocity Healthcare, the recently launched SBU (Strategic Business Unit) of Velocity MR, catering to the healthcare insights needs of marketers, manufacturers & governments, released the first part of its Covid Impact & Vaccine Perception Syndicated Study report. The first part encapsulates insightful data about the adoption of covid vaccination and the perception of leading corona vaccine brands. Apart from giving a pan-India narrative, the study compares overall data with
- Adult patient groups suffering from chronic ailments vs healthy adults vs geriatric group.
- Zone-wise Analysis – The analysis is based on zone-wise cities (North, South, East & West) with a sample size of 1078 respondents.
The second part of the report which focused on ‘The impact of Covid on Indians’ is due in the next few days.
Velocity Healthcare conducted the pan-India survey of people divided into two broad age groups:
(a) Adults of 20-55 years of age AND (b) geriatric group (55+ yrs).
The adult group (20-55 yrs) was further segmented basis their health condition they were suffering from. Broadly, people having Diabetes, Cardiac issues, Diabetic + Cardiac issues, and Healthy groups were selected. Also, only those suffering from these ailments for more than six months were taken into the sample.
21 cities from 4 regions of India were covered – North (Delhi, Indore, Jaipur, Chandigarh, Amritsar), South (Bangalore, Chennai, Hyderabad, Vizag), East (Kolkata, Lucknow, Patna, Varanasi, Bhubaneshwar, Guwahati), West (Ahmedabad, Mumbai, Pune, Nagpur, Surat, Vadodara).
The first part of the study reveals that around 85% of respondents want to get vaccinated from COVID & 80% of those found covid positive also wants to get vaccinated, whereas 15% have said that they do not want to get themselves vaccinated. The biggest motivators for getting vaccinated are building immunity against the virus (44%), followed by not being a threat to family/friends (39%), & getting back to the usual lifestyle (32%).
The report further states that if given the option of selecting the vaccine brand, overall around 45% would be indifferent, but a counter opinion was observed among Diabetics and Diabetic + Cardiac group where 65% of these would prefer choosing a brand of their choice.
The findings of the study corroborate the government’s narrative of Atmanirbhar Bharat as the indigenously made Covaxin and Covishield lead the list of vaccine brands in terms of awareness with total recall at 86% and 76%, respectively. However, Covaxin remains the most recalled brand at an unaided level.
Jasal Shah, Managing Director & CEO, Velocity MR states, “Almost hitting the complete year as the tsunami of sufferings, we are very close to the light, at the end of the tunnel. The report’s inferences make me glad that the country has a vaccine powerhouse and how the public carries its strong interest in getting vaccinated by vaccines. Also, it’s remarkable how our doctors and healthcare staff have worked day and night in quick time by vaccinating around 4.2cr public & strengthening the fight against coronavirus pandemic. Thank you for answering the calls to serve humanity. We know the battle is not over yet, but we can see the light at the end of the tunnel now, hopefully.”
Highlights of the Study
Perception about leading corona vaccine brands
- Findings of the report highlight that recall of Indian corona vaccine brands range from 30-85% and that for International brands between 35-75%
- Among Indian brands – Covaxin and Covishield lead the list with total recall at 86% and 76%, respectively.
- Covaxin was the most recalled brand at unaided level, amongst all vaccine brands.
- On the other hand, among the international vaccine brands – Pfizer’s vaccine brand tops the overall recall at 75%
- Among all the popular corona vaccine brands, Made in India brands are more promising, expressed by over 65% of people, with Covaxin and Covishield leading the list. Driven by the spirit of global well-being, the manufacturing of these two vaccines is the major achievement of Atmanirbhar Bharat Abhiyan.
Covaxin vs. Covishield as most promising vaccine brand
- Being an Indian brand stands out as an important reason to believe Covaxin as promising by 50-60% of people – thereby believing in the Make in India Mission.
- While for Covishield, reasons relating to efficacy, strain coverage, and Indian brand are almost equally expressed.
- When asked about efficiency perception; the majority of people felt the efficiency of their most perceived promising vaccine brand would be between 70-90%
- More than 90% of people felt that the efficiency of Covisheild would be between 70-90%; while for Covaxin, 85% of people felt its efficiency would be between 70-90%
- The report covers the trends and preferences of the corona vaccine brands based on
- Health condition and age status (diabetic vs cardiac vs cardiac+diabetic vs healthy vs geriatric) and
- Zone (North vs East vs West vs South) where they reside.
Does everyone want to get vaccinated against corona?
There is a high level of eagerness (4.2/5) among people for corona vaccines to be available in the Indian market and the majority (85%) wish to get themselves vaccinated against corona.
Main reasons for getting vaccinated
- People have multiple motivations for getting a corona vaccine jab with ‘building immunity’ being the most critical.
- Ensuring that he/she is not a carrier of the virus for their family, and
- Freedom from the mental fear of getting the virus being the other key motivator.
- The most resonated aspect of vaccination decision is on the ‘Trust on immunity that the vaccine would provide after 2 doses’ which is expressed by a little more than 1/3rd people
- Other aspects which may influence the decision of vaccination such as
- trust on R&D by a vaccine manufacturer,
- complying with an initiative by the Govt of India,
- The belief that vaccine will have minor side effects,
- The belief that vaccine will help in getting life to normal and
- The belief that vaccine will have no side effects
- are expressed by 10-15% people each
Why do people not wish to get vaccinated?
- 15% have said that they do not want to get themselves vaccinated.
- ‘First will wait and watch the results’ and ‘Worried about side effects’ are key barriers among this faction of people to not get vaccinated against corona
- The report covers the trends and preferences of the corona vaccine brands based on
- health condition and age status (diabetic vs cardiac vs cardiac+diabetic vs healthy vs geriatric) and
- zone (North vs East vs West vs South) where they reside.
About Velocity Healthcare
Velocity Healthcare is a tech-savvy healthcare insights provider that aims to provide reliable & actionable insights backed by quality data from global proprietary healthcare panels in 19+ countries with 150+ medical specialties. The need for healthcare insights has never been so realized ever before for marketers, manufacturers & governments. In the pursuit to help healthcare & allied services, Velocity Healthcare aims to provide reliable & actionable insights backed by quality data from proprietary healthcare panels & technology to add efficiency & reduce redundancies. In a nutshell, we’re the healthcare full-service research agency for end-to-end execution of primary market research.
